Biomarin Pharmaceutical Inc (BMRN)
63.45
+0.89
(+1.42%)
USD |
NASDAQ |
Nov 21, 16:00
63.44
-0.01
(-0.02%)
After-Hours: 20:00
Biomarin Pharmaceutical Max Drawdown (5Y): 52.14% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 52.14% |
September 30, 2024 | 56.53% |
August 31, 2024 | 56.90% |
July 31, 2024 | 56.90% |
June 30, 2024 | 56.90% |
May 31, 2024 | 56.90% |
April 30, 2024 | 56.90% |
March 31, 2024 | 56.90% |
February 29, 2024 | 56.90% |
January 31, 2024 | 56.90% |
December 31, 2023 | 56.90% |
November 30, 2023 | 56.90% |
October 31, 2023 | 56.90% |
September 30, 2023 | 56.90% |
August 31, 2023 | 56.90% |
July 31, 2023 | 56.90% |
June 30, 2023 | 56.90% |
May 31, 2023 | 56.90% |
April 30, 2023 | 56.90% |
March 31, 2023 | 56.90% |
February 28, 2023 | 56.90% |
January 31, 2023 | 56.90% |
December 31, 2022 | 56.90% |
November 30, 2022 | 56.90% |
October 31, 2022 | 56.90% |
Date | Value |
---|---|
September 30, 2022 | 56.90% |
August 31, 2022 | 56.90% |
July 31, 2022 | 56.90% |
June 30, 2022 | 56.90% |
May 31, 2022 | 56.90% |
April 30, 2022 | 56.90% |
March 31, 2022 | 56.90% |
February 28, 2022 | 56.90% |
January 31, 2022 | 56.90% |
December 31, 2021 | 56.90% |
November 30, 2021 | 56.90% |
October 31, 2021 | 56.90% |
September 30, 2021 | 56.90% |
August 31, 2021 | 56.90% |
July 31, 2021 | 56.90% |
June 30, 2021 | 56.90% |
May 31, 2021 | 56.90% |
April 30, 2021 | 56.90% |
March 31, 2021 | 56.90% |
February 28, 2021 | 56.90% |
January 31, 2021 | 56.90% |
December 31, 2020 | 56.90% |
November 30, 2020 | 56.90% |
October 31, 2020 | 56.90% |
September 30, 2020 | 56.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
52.14%
Minimum
Oct 2024
56.90%
Maximum
Nov 2019
56.82%
Average
56.90%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Merck & Co Inc | 27.26% |
Bristol-Myers Squibb Co | 47.67% |
Pfizer Inc | 54.78% |
Biogen Inc | 58.04% |
Moderna Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -8.471 |
Beta (5Y) | 0.3116 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 35.55% |
Historical Sharpe Ratio (5Y) | -0.1251 |
Historical Sortino (5Y) | -0.1652 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.55% |